MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Executive summary 2020 will go down in history as the year when the global community was
awakened to the fragility of human health and the interdependence of the ecosystem …

The rising predominance of type 2 diabetes, combined with the poor medical effects seen
with commercially available anti-diabetic medications, has motivated the development of …

At least 45% of patients with type 2 diabetes (T2D) fail to achieve adequate glycemic control
(HbA1c< 7%). One of the major contributing factors is poor medication adherence. Poor …

Diabetes retinopathy (DR) is a leading cause of vision loss in middle‐aged and elderly
people globally. Early detection and prompt treatment allow prevention of diabetes‐related …

Background Medication nonadherence in patients with chronic diseases, particularly in type
2 diabetes mellitus (T2DM) with comorbidity, has continued to be the cause of treatment …

Diabetes is a chronic illness that places a significant self-management burden on affected
individuals and families. Given the importance of health behaviors—such as medication …

Adherence to therapy is defined as the extent to which a person's behavior in taking
medication, following a diet, and/or executing lifestyle changes, corresponds with agreed …

Despite US Food and Drug Administration (FDA) approval of over 40 new treatment options
for type 2 diabetes since 2005, the latest data from the National Health and Nutrition …

Background Type 2 diabetes mellitus has been identified as one of the most challenging
chronic illnesses to manage. Since the management of diabetes is mainly accomplished by …